학술논문

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 2024, 14)
Subject
Language
English
ISSN
2234943X